Cargando…
Erratum to identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459618/ https://www.ncbi.nlm.nih.gov/pubmed/36090628 http://dx.doi.org/10.21037/tlcr-2022-4 |
| _version_ | 1784786554339721216 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9459618 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94596182022-09-10 Erratum to identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance Transl Lung Cancer Res Erratum AME Publishing Company 2022-08 /pmc/articles/PMC9459618/ /pubmed/36090628 http://dx.doi.org/10.21037/tlcr-2022-4 Text en 2022 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Erratum Erratum to identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance |
| title | Erratum to identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance |
| title_full | Erratum to identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance |
| title_fullStr | Erratum to identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance |
| title_full_unstemmed | Erratum to identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance |
| title_short | Erratum to identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance |
| title_sort | erratum to identification of gpx4 as a therapeutic target for lung adenocarcinoma after egfr-tki resistance |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459618/ https://www.ncbi.nlm.nih.gov/pubmed/36090628 http://dx.doi.org/10.21037/tlcr-2022-4 |
| work_keys_str_mv | AT erratumtoidentificationofgpx4asatherapeutictargetforlungadenocarcinomaafteregfrtkiresistance |